Preventable and mitigable adverse events in cancer care: Measuring risk and harm across the continuum.

Abstract:

BACKGROUND:Patient safety is a critical concern in clinical oncology, but the ability to measure adverse events (AEs) across cancer care is limited by a narrow focus on treatment-related toxicities. The objective of this study was to assess the nature and extent of AEs among cancer patients across inpatient and outpatient settings. METHODS:This was a retrospective cohort study of 400 adult patients selected by stratified random sampling who had breast (n = 128), colorectal (n = 136), or lung cancer (n = 136) treated at a comprehensive cancer center in 2012. Candidate AEs, or injuries due to medical care, were identified by trained nurse reviewers over the course of 1 year from medical records and safety-reporting databases. Physicians determined the AE harm severity and the likelihood of preventability and harm mitigation. RESULTS:The 400-patient sample represented 133,358 days of follow-up. Three hundred four AEs were identified for an overall rate of 2.3 events per 1000 patient days (91.2 per 1000 inpatient days and 0.9 per 1000 outpatient days). Thirty-four percent of the patients had 1 or more AEs (95% confidence interval, 29%-39%), and 16% of the patients had 1 or more preventable or mitigable AEs (95% confidence interval, 13%-20%). The AE rate for patients with breast cancer was lower than the rate for patients with colorectal or lung cancer (P ≤ .001). The preventable or mitigable AE rate was 0.9 per 1000 patient days. Six percent of AEs and 4% of preventable AEs resulted in serious harm. Examples included lymphedema, abscess, and renal failure. CONCLUSIONS:A heavy burden of AEs, including preventable or mitigable events, has been identified. Future research should examine risk factors and improvement strategies for reducing their burden. Cancer 2017;123:4728-4736. © 2017 American Cancer Society.

journal_name

Cancer

journal_title

Cancer

authors

Lipitz-Snyderman A,Pfister D,Classen D,Atoria CL,Killen A,Epstein AS,Anderson C,Fortier E,Weingart SN

doi

10.1002/cncr.30916

subject

Has Abstract

pub_date

2017-12-01 00:00:00

pages

4728-4736

issue

23

eissn

0008-543X

issn

1097-0142

journal_volume

123

pub_type

杂志文章

相关文献

CANCER文献大全
  • Squamous cell carcinoma of the buccal mucosa associated with chronic oral polyvinyl chloride exposure: report of a case.

    abstract::The following case report describes a 22-year-old healthy man, non-smoker, non-drinker, who developed a squamous cell carcinoma of the buccal mucosa. The appearance of this unusual tumor in an unexpected clinical setting was unexplained until it was discovered that the patient had a lifetime habit of chewing plastic m...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197704)39:4<1686::aid-cncr282039

    authors: Casterline CL,Casterline PF,Jaques DA

    更新日期:1977-04-01 00:00:00

  • Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005).

    abstract:BACKGROUND:The AKT inhibitor MK-2206 at a dose of 60 mg every other day was evaluated in gastric/gastroesophageal junction cancers. METHODS:Patients who had progressed after first-line treatment were eligible. Pertinent eligibility criteria included adequate organ function, a fasting serum glucose level ≤ 150 mg/dL, a...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.29363

    authors: Ramanathan RK,McDonough SL,Kennecke HF,Iqbal S,Baranda JC,Seery TE,Lim HJ,Hezel AF,Vaccaro GM,Blanke CD

    更新日期:2015-07-01 00:00:00

  • Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors.

    abstract:BACKGROUND:The objective of the current study was to investigate the effects and the morbidities of single-fraction stereotactic radiation therapy (SRT) for lung tumors. METHODS:A Microtron device was modified to deliver stereotactic irradiation under respiratory gating. Between August 1998 and December 2004, 59 malig...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21747

    authors: Hara R,Itami J,Kondo T,Aruga T,Uno T,Sasano N,Ohnishi K,Kiyozuka M,Fuse M,Ito M,Naoi K,Kohno Y

    更新日期:2006-03-15 00:00:00

  • Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-year experience at a single institute.

    abstract:BACKGROUND:The authors evaluated the efficacy of adjuvant chemotherapy with 5-fluorouracil (5-FU) plus doxorubicin in gastric carcinoma after D2-3 curative resection. They also evaluated the effect of dose-related factors (delivered total dose/m(2), actual dose intensity [ADI], relative dose intensity [RDI]) of this re...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(20010601)91:11<2016::aid-cncr122

    authors: Jeung HC,Rha SY,Noh SH,Min JS,Kim BS,Chung HC

    更新日期:2001-06-01 00:00:00

  • High dose methotrexate followed by citrovorum factor reversal in patients with advanced cancer.

    abstract::High dose methotrexate followed by citrovorum factor reversal has been utilized in twenty-six patients with advanced cancer. Four of 10 patients with head and neck cancer had an objective response. One of 7 patients with metastatic osteosarcoma to the lungs had stabilization with twenty treatments over 23 months. One ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197904)43:4<1177::aid-cncr282043

    authors: Ambinder EP,Perloff M,Ohnuma T,Biller HF,Holland JF

    更新日期:1979-04-01 00:00:00

  • Effectiveness of high-dose MCNU therapy and hematopoietic stem cell autografts treatment of childhood acute leukemia/lymphoma with high-risk features.

    abstract::Clinical and pharmacokinetic studies were performed regarding the toxicity of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) with other drugs, in conjunction with a peripheral blood stem cell autograft (PBSCT), for treating 26 children with acute leukemia or lymphoma associated wit...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19910401)67:7<1830::aid-cncr2820

    authors: Takaue Y,Watanabe T,Hoshi Y,Abe T,Matsunaga K,Saito S,Hirao A,Kawano Y,Ninomiya T,Kuroda Y

    更新日期:1991-04-01 00:00:00

  • Observations of serum trace elements in chronic lymphocytic leukemia.

    abstract::Serum trace elements (STE) were measured in 50 patients with chronic lymphocytic leukemia (CLL) and 100 normal subjects. Copper was higher in patients than in controls (1.50 +/- 0.06 versus 1.10 +/- 0.02 micrograms/ml, P less than 0.001), increased steadily from Stage 0 to Stage 4 (P = 0.002), and correlated with the ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19871015)60:8<1842::aid-cncr2820

    authors: Beguin Y,Brasseur F,Weber G,Bury J,Delbrouck JM,Roelandts I,Robaye G,Fillet G

    更新日期:1987-10-15 00:00:00

  • Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma.

    abstract:BACKGROUND:In this report, the authors present the results from a study of patients with unresectable oropharyngeal squamous cell carcinomas who were treated on a protocol of hyperfractionated radiation and high-dose intraarterial cisplatin (HYPERRADPLAT) at the University of Kentucky. METHODS:The study was designed a...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21368

    authors: Spring PM,Valentino J,Arnold SM,Sloan D,Kenady D,Kudrimoti M,Haydon RC 3rd,Lee C,Given C,Mohiuddin M,Regine WF

    更新日期:2005-10-15 00:00:00

  • Specific expression of the ras-related rab3A gene in human normal and malignant neuroendocrine cells.

    abstract:BACKGROUND:The authors originally demonstrated the tissue-specific expression of the rab3A gene in the mouse brain. In the current study, they analyze the activity of this gene in fresh human tumors associated with neuronal phenotype compared with normal and malignant cells from other origins. METHODS:The authors stud...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19921115)70:10<2552::aid-cncr282

    authors: Culine S,Rousseau-Merck MF,Honoré N,Nezelof C,Olofsson B

    更新日期:1992-11-15 00:00:00

  • Bendamustine: a new look at an old drug.

    abstract::Alkylating agents form the basis of most combination treatment regimens for low-grade lymphoproliferative disorders. Bendamustine is a unique alkylating agent that has distinctive preclinical activity in cell lines resistant to other alkylators. Furthermore, clinical activity has been demonstrated in patients with alk...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.24057

    authors: Kalaycio M

    更新日期:2009-02-01 00:00:00

  • Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer.

    abstract:BACKGROUND:Male breast cancer (MBC) is considered an androgen-dependent tumor, and as in prostatic cancer, responses have been reported with use of antiandrogens or gonadotropin-releasing hormone analogs. Thus, it is reasonable to postulate that better results could be achieved by combining these two agents. METHODS:E...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19930715)72:2<502::aid-cncr28207

    authors: Lopez M,Natali M,Di Lauro L,Vici P,Pignatti F,Carpano S

    更新日期:1993-07-15 00:00:00

  • Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma.

    abstract:BACKGROUND:Parathyroid hormone-related peptide (PTHrP) is a tumor-derived circulating factor that has been associated with hypercalcemia of malignancy. The role of PTHrP as a prognostic indicator remains unclear. Studies suggest that it may function as a growth factor; and, recently, the ability of PTHrP to induce cyto...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20972

    authors: Deans C,Wigmore S,Paterson-Brown S,Black J,Ross J,Fearon KC

    更新日期:2005-05-01 00:00:00

  • Multivariate analysis for histologic prognostic factors in soft tissue sarcomas.

    abstract::To investigate histologic prognostic factors in soft tissue sarcomas (STS), multivariate analysis was performed on 236 patients with complete clinical information. These included 141 males and 95 females with an age range from 1 to 85 years (median, 47.6 years). Histologically, malignant fibrous histiocytoma (33.5%) w...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880901)62:5<994::aid-cncr28206

    authors: Tsujimoto M,Aozasa K,Ueda T,Morimura Y,Komatsubara Y,Doi T

    更新日期:1988-09-01 00:00:00

  • Sentinel lymph node biopsy in patients with papillary thyroid carcinoma.

    abstract:BACKGROUND:It remains controversial whether modified radical neck dissection (MRND) for patients with papillary thyroid carcinoma improves prognosis. However, it is highly probable that the incidence of local recurrence is reduced by lymph node dissection. Sentinel lymph node (SLN) biopsy (SLNB) for patients with melan...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20011201)92:11<2868::aid-cncr101

    authors: Fukui Y,Yamakawa T,Taniki T,Numoto S,Miki H,Monden Y

    更新日期:2001-12-01 00:00:00

  • Immunologic enhancement of B16 melanoma growth.

    abstract::In certain experimental tumor models, tumor growth is less pronounced in immune deficient animals. Characteristically, tumors such as the murine B16 melanoma and Lewis lung carcinoma (3LL) are weakly antigenic. We proposed that with such tumors that are weakly antigenic, growth is enhanced by T-cell factors. Young mic...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880501)61:9<1792::aid-cncr2820

    authors: Ershler WB,Tuck D,Moore AL,Klopp RG,Kramer KE

    更新日期:1988-05-01 00:00:00

  • Symptoms and rehabilitation needs of patients with early stage breast cancer during primary therapy.

    abstract::The treatment for women diagnosed with early breast cancer is complex, dynamic, and controversial. More choices are available for local control and indications for systemic adjuvant therapy have changed dramatically. Knowledge of predictable physical and psychological responses through the various phases of primary tr...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19900915)66:14+<1392::aid-cncr28

    authors: Knobf MT

    更新日期:1990-09-15 00:00:00

  • Intraoperative radiotherapy for advanced carcinoma of the biliary system.

    abstract::Since November 1973, intraoperative radiotherapy has been performed on five patients with unresectable, advanced carcinoma of the bile duct at the hepatic hilus and six patients with unresectable carcinoma of the gallbladder. A treatment cone with a diameter ranging from 4--10 cm was directly applied at the lesion. A ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19801115)46:10<2179::aid-cncr282

    authors: Todoroki T,Iwasaki Y,Okamura T,Nagoshi K,Asakura H,Nakano M,Inada T,Tsunemoto H,Umegaki Y,Nishimura A,Nakano M,Sato H

    更新日期:1980-11-15 00:00:00

  • Activity of 9-nitro-camptothecin, an oral topoisomerase I inhibitor, in myelodysplastic syndrome and chronic myelomonocytic leukemia.

    abstract:BACKGROUND:Topoisomerase I inhibitors, like topotecan, have activity in myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML). 9-Nitro-camptothecin (9-NC) is a new oral topoisomerase inhibitor with a good safety profile. The aims of the current study were to evaluate the activity and safety of 9-NC ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/cncr.22186

    authors: Quintas-Cardama A,Kantarjian H,O'Brien S,Jabbour E,Giles F,Ravandi F,Faderl S,Pierce S,Shan J,Verstovsek S,Cortes J

    更新日期:2006-10-01 00:00:00

  • Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: a population-based cohort study in Sweden.

    abstract:BACKGROUND:Pathologically, benign prostatic hyperplasia (BPH) is not considered a precursor for prostate carcinoma. However, because the two conditions share not only a similar hormonal environment within the prostate but also several common risk factors, it is possible that men with BPH may be at increased risk of pro...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11710

    authors: Chokkalingam AP,Nyrén O,Johansson JE,Gridley G,McLaughlin JK,Adami HO,Hsing AW

    更新日期:2003-10-15 00:00:00

  • Cancer and total mortality among active Mormons.

    abstract::Based on Church records for 15,500 California Mormons during 1968 to 1975 and for 55,000 Utah Mormons during 1970 and 1975, the ratio of age-adjusted death rates for religiously active Mormon males compared with U.S. white males is 38% for ages 35 to 64 years and 50% for ages 35 years and above. The remaining life exp...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197810)42:4<1943::aid-cncr282042

    authors: Enstrom JE

    更新日期:1978-10-01 00:00:00

  • Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors.

    abstract:BACKGROUND:The Female Sexual Function Index (FSFI) is the most commonly used self-report instrument to measure sexual functioning among women cancer survivors. Despite this, the validity and reliability of the FSFI for use in cancer populations has not been established. METHODS:Data were combined from 3 separate insti...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26739

    authors: Baser RE,Li Y,Carter J

    更新日期:2012-09-15 00:00:00

  • VAB-3 combination chemotherapy of metastatic testicular cancer.

    abstract::The initial response and long-term follow-up of 74 evaluable patients who received combination chemotherapy for metastatic nonseminomatous testicular cancer are reported. Patients were treated with a protocol (VAB-3) including vinblastine, actinomycin-D, bleomycin, and cis-dichlorodiammine platinum (DDP). VAB-3 alone ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19810815)48:4<888::aid-cncr28204

    authors: Reynolds TF,Vugrin D,Cvitkovic E,Cheng E,Braun DW Jr,O'Hehir MA,Dukeman ME,Whitmore WF Jr,Golbey RB

    更新日期:1981-08-15 00:00:00

  • Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.

    abstract::Two patients diagnosed as having acute promyelocytic leukemia (APL) and disseminated intravascular coagulation (DIC) were closely followed from the day of admission until completion of the first course of chemotherapy with serial coagulation studies including plasma levels of functional antithrombin III activity (AT I...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19830215)51:4<681::aid-cncr28205

    authors: Sandler RM,Liebman HA,Patch MJ,Teitelbaum A,Levine AM,Feinstein DI

    更新日期:1983-02-15 00:00:00

  • A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma.

    abstract:BACKGROUND:Thalidomide is an antiangiogenic agent with immune modulating potential. The objective of this study was to determine response rates among women who were treated for recurrent ovarian cancer using topotecan with or without thalidomide. METHODS:Women were enrolled in this multicenter, prospective, randomized...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.23164

    authors: Downs LS Jr,Judson PL,Argenta PA,Ghebre R,Geller MA,Bliss RL,Boente MP,Nahhas WA,Abu-Ghazaleh SZ,Chen MD,Carson LF

    更新日期:2008-01-15 00:00:00

  • Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.

    abstract:BACKGROUND:BRCA2 gene, located at chromosome 13q12.3, frequently is altered in familial types of cancer in which a "double-hit" inactivation model seems to occur. In contrast, in sporadic forms of cancer there is frequent absence of a second event (point mutations) suggesting that allelic imbalance at the BRCA2 locus m...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20001101)89:9<1933::aid-cncr9>3.

    authors: Gorgoulis VG,Kotsinas A,Zacharatos P,Mariatos G,Liloglou T,Tsoli E,Kokotas S,Fassoulas C,Field JK,Kittas C

    更新日期:2000-11-01 00:00:00

  • Physical activity and survival of postmenopausal, hormone receptor-positive breast cancer patients: results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle study.

    abstract:BACKGROUND:Physical activity has been related to improved breast cancer outcomes. Especially in the older breast cancer population, physical activity may be important because old age is associated with comorbidities and decreased physical function. The purpose of this study was to investigate the relation between physi...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1002/cncr.28783

    authors: de Glas NA,Fontein DB,Bastiaannet E,Pijpe A,De Craen AJ,Liefers GJ,Nortier HJ,de Haes HJ,van de Velde CJ,van Leeuwen FE

    更新日期:2014-09-15 00:00:00

  • Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.

    abstract:BACKGROUND:Upfront autologous hematopoietic stem cell transplantation (AHCT) remains an important therapy in the management of patients with multiple myeloma (MM), a disease of older adults. METHODS:The authors investigated the outcomes of AHCT in patients with MM who were aged ≥70 years. The Center for International ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33171

    authors: Munshi PN,Vesole D,Jurczyszyn A,Zaucha JM,St Martin A,Davila O,Agrawal V,Badawy SM,Battiwalla M,Chhabra S,Copelan E,Kharfan-Dabaja MA,Farhadfar N,Ganguly S,Hashmi S,Krem MM,Lazarus HM,Malek E,Meehan K,Murthy HS,Ni

    更新日期:2020-12-01 00:00:00

  • Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: a population-based study.

    abstract:BACKGROUND:The National Quality Forum endorses the recommendation of examining at least 12 lymph nodes (LNs) from colorectal cancer (CRC) specimens. However, heterogeneity in LN harvest exists. The objective of this study was to investigate the clinicopathologic factors that influence LN yield. METHODS:The authors use...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25032

    authors: Chou JF,Row D,Gonen M,Liu YH,Schrag D,Weiser MR

    更新日期:2010-06-01 00:00:00

  • Estimates of lead time and length bias in a breast cancer screening program.

    abstract::Assume that the benefit of screening for breast cancer with a combination of mammography and a clinical examination is measured by comparing the five-year survival rate of women detected by screening to the five-year survival rate of women surface clinically with breast cancer, e.g., to the survival rate of women repo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800815)46:4<844::aid-cncr28204

    authors: Shwartz M

    更新日期:1980-08-15 00:00:00

  • Cancer mortality in Chinese immigrants to New York City. Comparison with Chinese in Tianjin and with United States-born whites.

    abstract:BACKGROUND:Cancer rates in immigrant populations are frequently found to be intermediate between the country of origin and the adopted country. Such observations play an important role in establishing the environmental origin of cancer. Chinese now constitute the third largest group immigrating to New York City. METHO...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19940215)73:4<1270::aid-cncr2820

    authors: Stellman SD,Wang QS

    更新日期:1994-02-15 00:00:00